Summary:
Early cancer detection is an attractive and promising application for liquid biopsy that might revolutionize cancer screenings. In this issue of Cancer Discovery, Foda and colleagues expand the potential utility of a machine learning fragmentome-based model, called DELFI, for detecting liver cancer in high-risk patients.
©2023 American Association for Cancer Research
2023
American Association for Cancer Research
You do not currently have access to this content.